MD, PhD, MBA
Dr. David Greene, MD, PhD, MBA, stands at the forefront of regenerative medicine and healthcare innovation, blending clinical expertise with entrepreneurial vision. As the founder and CEO of R3 Stem Cell and US Lead Network, Dr. Greene has dedicated his career to advancing patient care and empowering medical practices through advanced therapies and digital marketing excellence.
A residency and fellowship-trained orthopedic surgeon, Dr. Greene began his journey in medicine with a deep commitment to helping others. After years in clinical practice, he recognized the transformative potential of regenerative therapies and the urgent need for better patient access and education. This insight led him to establish R3 Stem Cell, now a global leader in non-surgical treatment options using stem cell and PRP therapy. Under his leadership, R3 Stem Cell has performed over 26,000 procedures across more than 45 international clinics, offering hope and healing to patients worldwide.
Dr. Greene’s entrepreneurial spirit didn’t stop at clinical innovation. He also founded US Lead Network, a healthcare internet marketing company that leverages artificial intelligence to help medical and dental practices grow their patient base efficiently and ethically. His two books on healthcare internet marketing have become essential reading for providers seeking to navigate the complexities of digital patient acquisition. Recognized as a Top 20 Expert Author by Ezines.com – ranking #15 out of over 470,000 authors and #1 in Pain Management – Dr. Greene’s thought leadership has shaped the way healthcare professionals connect with patients online.
A defining moment in Dr. Greene’s career was his decision to leave clinical practice and focus entirely on innovation and education. “I’ve never been a fan of just settling for the status quo. Innovation is a cornerstone of what makes America great,” he reflects. This philosophy has driven R3 Stem Cell’s mission to provide affordable, high-quality regenerative care and to demystify stem cell therapies through comprehensive training courses and educational content for both providers and patients.
Dr. Greene’s work has garnered international recognition, including a feature on the cover of Corporate Vision magazine, where his commitment to affordable, accessible regenerative therapies was spotlighted. His impact extends beyond business metrics – he is known for his compassionate approach, always prioritizing patient education and ethical practice.
Outside of his professional life, Dr. Greene is inspired by the words of Maya Angelou: “My mission in life is not merely to survive, but to thrive; and to do so with some passion, some compassion, some humor, and some style”. He brings this ethos to his daily work, fostering a culture of innovation, empathy, and continuous learning.
When he’s not leading global healthcare initiatives, Dr. Greene enjoys sharing insights on social media, connecting with colleagues, and pursuing personal interests that keep him grounded and inspired.
Dr. David Greene’s journey is a testament to the power of combining clinical skill, business acumen, and a heartfelt commitment to making a difference – one patient, one practice, and one innovation at a time.
All Posts
One medical condition that affects older people, particularly women, is trigeminal neuralgia. This condition is a result of a long-term condition and the periods of remission often get shorter over time. What exactly is Trigeminal Neuralgia, and what are the best treatment options available? Read
SCOTTSDALE, ARIZONA, USA, December 20, 2022 R3 Stem Cell International, the global leader in regenerative therapies, is now offering stem cell therapy for premature ovarian failure (POF). The results have been exceptional for POF, with many women achieving success. R3 offers treatments at its international
Stem cell therapy for infertility due to premature ovarian failure (POF) is now being offered by R3 Stem Cell at several Centers globally. The treatment has been very effective in select patients, with successful pregnancies and/or success with IVF resulting. Recently, R3 Stem Cell’s research
Gene and stem cell therapy are at the cutting edge of modern medicine, offering renewed hope to patients dealing with severe medical conditions. Previously considered a stretch of the imagination, stem cell therapy has proven effective in improving the quality of life for several patients,
Stem cell treatment is still pretty new in the healthcare industry. Yet, our current knowledge of this type of treatment makes it possible to delay the effects of aging by improving an elder’s health and lifespan. There is an underlying link between stem cells and
Another episode of Coffee with Colin by which Colin Egglesfield interviews Dr. David Greene about R3 Stem Cell and how it started and how helpful stem cell therapy is for various medical conditions. Get a deep knowledge about stem cell therapy and find out what
Acclaimed TV star, actor, host, and presenter Cameron Mathison has teamed up with R3 Stem Cell. #Powerjournalist Markos Papadatos has the scoop. Mathison shared that he has teamed up with R3 Stem Cell, in an effort to benefit from their advanced technology. “This is incredible,”
The best exosome therapies in Phoenix and Scottsdale Arizona are provided by R3 Stem Cell. This includes exosome facials, exosomes for erectile dysfunction, exosomes for hair restoration and exosomes for joint pain of the knee, hip, shoulder, wrist, elbow and more. Not only is R3
The corneas are very sensitive tissues that cover the front of the eye. And while they may seem fragile, they protect other more delicate parts of the eye and refract light entering the eye. Unsurprisingly, corneas are critical to our sight, and their damage could
Light chain amyloidosis results from clonal plasma cells; however, cell therapy directed against these clone cells has remained the most effective treatment for the condition. Over time, autologous stem cell transplantation (ASCT) has become a critical treatment resource for addressing light-chain amyloidosis. Following ASCT, patients
